Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

A review meeting was also held with top officials on Monday to take stock of the situation --- with the union health ministry ...

Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm ...

What sets JN.1 apart is a unique mutation in the spike protein — the part of the virus that binds to human cells. This ...

Indian health authorities are monitoring rising COVID-19 cases in Singapore and Hong Kong while asserting that the situation ...

There have been more instances of a management team buying out the owners of a company after the pandemic. There are eight ...